CAP方案治疗晚期膀胱癌30例疗效分析  

The analysis of 30 patients with advanced bladder cancer using chemotherapy with CAP regimen

作　　者：李少梅[1] 陈学明[1] 

机构地区：[1]山东省烟台市莱阳中心医院

出　　处：《齐鲁肿瘤杂志》1999年第2期123-124,共2页

摘　　要：目的：观察ＣＡＰ方案对晚期膀胱癌的疗效和不良反应。方法：ＣＴＸ６００～８００ｍｇ／ｍ２静注ｄ１，ＡＤＭ３０～４０ｍｇ／ｍ２静注ｄ１，ＤＤＰ２０ｍｇ／ｍ２静滴ｄ１～５，３周为一周期。结果：ＣＲ８例（２６６％），ＰＲ１２例（４０％），ＮＣ６例（２０％），ＰＤ４例（１３３％）。结论：ＣＡＰ方案对治疗晚期膀胱癌有效，不良反应少。Objective: To observe the effect and adverse reactions of CAP regimen for treating advanced bladder cancer Methods: CTX 600800mg/m2 iv d1,ADM 3040mg/m2 iv d1, DDP 20mg/m2 ivdrip d15. Three weeks for one cycle. Results: CR 8 cases (266%),PR 12 cases (40%),NC 6 cases (20%),PD 4 cases (133%). Conclusions: CAP regimen is effective in treating advanced bladder cancer and there is few harmful reactions.

关 键 词：膀胱癌 CAP方案 晚期 疗效 

分 类 号：R730.53[医药卫生—肿瘤] R737.140.5[医药卫生—临床医学]